Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis.

Autor: Kang, Zian1 (AUTHOR), Jin, Yuqing2 (AUTHOR), Yu, Huihui3 (AUTHOR), Li, Su1 (AUTHOR), Qi, Yingjie1 (AUTHOR) princessqyj@sina.com
Zdroj: BMC Cancer. 6/8/2024, Vol. 24 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje